journal article·2026-04Open access

Targeted Mitochondrial ECSIT Overexpression Attenuates MASH by Increasing OTUD3 Expression

Yuqing Jiang, Tingting Tong, Pengxi Shi, Xiaofan Chen, Chenhao Wang, Qingyuan Weng, Sihan Chen, Linli Que, Qi Chen, Yuehua Li, Qiang Zhu, Jiantao Li

Advanced Science· Volume 13· Issue 22

Abstract

ABSTRACT Mitochondrial dysfunction plays a key role in the pathogenesis of metabolic dysfunction‐associated steatohepatitis (MASH). As is known to play a key role in mitochondria, ECSIT, in relation to oxidized mitochondrial DNA is still unclear. This study examines mitochondrial ECSIT expression in MASH mouse models. Mitochondria‐targeted ECSIT transgenic (ECSIT MTG ) mice and wild‐type (WT) controls are fed a high‐fat, high‐cholesterol (HFHC) diet for 16 weeks or a methionine‐ and choline‐deficient (MCD) diet for 8 weeks. Results demonstrate that mitochondrial ECSIT overexpression alleviates diet‐induced MASH phenotypes. Mechanistically, we demonstrate that mitochondrial ECSIT promotes the localization of the deubiquitinase OTUD3 to mitochondria. OTUD3 then stabilizes SIRT3 via deubiquitination, thereby inhibiting mtDNA oxidation and alleviating steatosis‐induced metabolic disorders. Overall, these findings indicate that mitochondrial ECSIT protects against MASH progression by stabilizing SIRT3, suggesting its potential as a therapeutic target.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Liver Disease Diagnosis and Treatment · Sirtuins and Resveratrol in Medicine · Biochemical Acid Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Targeted Intervention of Cardiovascular Disease Collaborative Innovation Center for Cardiovascular Disease Translational Medicine School of Basic Medical Science Nanjing Medical University Nanjing Jiangsu China

The First Clinical Medical College Nanjing Medical University Nanjing Jiangsu China

Department of Organ Transplantation Eastern Hepatobiliary Surgery Hospital Naval Medical University Shanghai China

Funding

National Natural Science Foundation of China

References (47)

Show source-provided references
1. 10.1146/annurev‐pathmechdis‐111523‐02343010.1146/annurev‐pathmechdis‐111523‐023430 ↗
2. 10.3390/ijms2607295910.3390/ijms26072959 ↗
3. 10.1038/s41575‐019‐0145‐710.1038/s41575‐019‐0145‐7 ↗
4. 10.1038/s41575‐024‐00990‐510.1038/s41575‐024‐00990‐5 ↗
5. 10.1016/j.jhep.2022.09.02010.1016/j.jhep.2022.09.020 ↗
6. 10.1002/advs.20241198410.1002/advs.202411984 ↗
7. 10.3389/fphar.2024.146318710.3389/fphar.2024.1463187 ↗
8. 10.3389/fncel.2024.143445910.3389/fncel.2024.1434459 ↗
9. 10.1016/j.redox.2024.10322410.1016/j.redox.2024.103224 ↗
10. 10.1155/2022/729955510.1155/2022/7299555 ↗
11. 10.1089/ars.2017.717210.1089/ars.2017.7172 ↗
12. 10.1038/emboj.2010.3910.1038/emboj.2010.39 ↗
13. 10.1128/MCB.00030‐1310.1128/MCB.00030‐13 ↗
14. 10.1083/jcb.20061106410.1083/jcb.200611064 ↗
15. 10.1016/j.cmet.2022.05.00510.1016/j.cmet.2022.05.005 ↗
16. 10.1038/s41467‐021‐23219‐410.1038/s41467‐021‐23219‐4 ↗
17. 10.1016/j.bone.2017.12.02410.1016/j.bone.2017.12.024 ↗
18. 10.1016/j.isci.2021.10315310.1016/j.isci.2021.103153 ↗
19. 10.1016/j.tcb.2024.09.00310.1016/j.tcb.2024.09.003 ↗
20. 10.1002/advs.20241435810.1002/advs.202414358 ↗
21. 10.1016/j.intimp.2024.11352410.1016/j.intimp.2024.113524 ↗
22. 10.1038/s41392‐025‐02253‐410.1038/s41392‐025‐02253‐4 ↗
23. 10.1186/s12964‐020‐00637‐310.1186/s12964‐020‐00637‐3 ↗
24. 10.3390/antiox1308090610.3390/antiox13080906 ↗
25. 10.1038/290457a010.1038/290457a0 ↗
26. 10.1016/j.immuni.2022.06.00710.1016/j.immuni.2022.06.007 ↗
27. 10.1172/JCI8388510.1172/JCI83885 ↗
28. 10.3390/ijms2213685610.3390/ijms22136856 ↗
29. 10.1152/ajpheart.00832.201510.1152/ajpheart.00832.2015 ↗
30. 10.1016/j.freeradbiomed.2024.10.30210.1016/j.freeradbiomed.2024.10.302 ↗
31. 10.1016/j.redox.2023.10270710.1016/j.redox.2023.102707 ↗
32. 10.3389/fimmu.2025.153536210.3389/fimmu.2025.1535362 ↗
33. 10.1002/hep.3053710.1002/hep.30537 ↗
34. 10.1002/hep.3265110.1002/hep.32651 ↗
35. 10.1002/hep.2937510.1002/hep.29375 ↗
36. 10.1016/j.metabol.2023.15557910.1016/j.metabol.2023.155579 ↗
37. 10.1002/anie.20201154810.1002/anie.202011548 ↗
38. 10.1101/gad.114560310.1101/gad.1145603 ↗
39. 10.1016/j.isci.2021.10304710.1016/j.isci.2021.103047 ↗
40. 10.1002/advs.20220518010.1002/advs.202205180 ↗
41. 10.1038/nature0997310.1038/nature09973 ↗
42. 10.1074/jbc.M114.59718710.1074/jbc.M114.597187 ↗
43. 10.1016/j.cmet.2024.04.00610.1016/j.cmet.2024.04.006 ↗
44. 10.2337/dc22‐S00210.2337/dc22‐S002 ↗
45. 10.1097/HEP.000000000000147510.1097/HEP.0000000000001475 ↗
46. 10.1016/j.lfs.2024.12309510.1016/j.lfs.2024.123095 ↗
47. 10.1002/hep.2254110.1002/hep.22541 ↗